聚焦国家基本药物制度  

Focus on the National Essential Drug System

作　　者：金有豫[1] 

机构地区：[1]首都医科大学,北京市100069

出　　处：《中国药房》2010年第8期675-678,共4页China Pharmacy

摘　　要：目的:为促进我国医药卫生工作的发展提供参考。方法:回顾和思考我国国家基本药物制度的发展历程,参考借鉴世界卫生组织(WHO)的经验,并展望我国国家基本药物制度的发展方向。结果与结论:WHO提出"国家基本药物"的概念,并建议医疗机构建立药物和治疗学委员会(组)、编写《标准治疗指南》和《国家处方集》以管理国家基本药物的合理使用。30多年来,我国虽陆续制定了《国家基本药物目录》及相关政策,但因实施不力而效果不明显。2009版《国家基本药物目录·基层医疗卫生机构配备使用部分》和2010版《中国国家处方集·化学药品与生物制剂卷》的发布,标志着我国国家基本药物制度再次启动和发展。OBJECTIVE： To provide reference for promoting the development of medical and health care in China. METHODS ： The development process of national essential drug system was reviewed and analyzed and the experience of WHO was drawn on to design the future of national essential drug system in China. RESULTS ＆ CONCLUSION： WHO proposed the concept of national essential drugs and recommended medical institutions to establish drug and therapeutics committee and to prepare ＂Standard Treatment Guidelines＂ and ＂National Formulary＂ for management of rational use of national essential drug. While essential drug sys- tem and basic medical security system have been worked out in China, their impacts of them are not satisfactory because of weak enforcement. ＂National Essential Drugs List · The Part for Primary Health Care and Health Institutions＂ （2009 version） and National Formulary Indicate. The Part of Chemicals and Bidogical Products were published, and they are symbols of the re-beginning of national essential drug system.

关 键 词：国家基本药物制度 国家药物政策 药物与治疗学委员会 合理用药 国家处方集 标准治疗指南 

分 类 号：R95[医药卫生—药学]